Oramed Pharmaceuticals Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BML CAPITAL MANAGEMENT, LLC | 02/07/2025 | 2.64 M | $6.40 M | 20.94% | 6.46% |
MURCHINSON LTD. | 02/14/2025 | 1.75 M | $4.24 M | 2.46% | 4.28% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 845,188 | $2.05 M | 2.04% | 2.07% |
RATHBONES GROUP PLC | 02/13/2025 | 289,803 | $701,323 | 0.00% | 0.71% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 241,400 | $584,188 | -5.56% | 0.59% |
01/29/2025 | 227,239 | $549,918 | 100.00% | 0.56% | |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 167,653 | $405,720 | -2.64% | 0.41% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 151,808 | $367,375 | -38.11% | 0.37% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 118,995 | $287,968 | 143.82% | 0.29% |
UBS GROUP AG | 02/14/2025 | 112,981 | $273,414 | 300.87% | 0.28% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 110,378 | $267,115 | -22.10% | 0.27% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 107,062 | $259,090 | -4.00% | 0.26% |
BLACKROCK, INC. | 02/07/2025 | 93,705 | $226,766 | 1.84% | 0.23% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 91,027 | $220,285 | -32.26% | 0.22% |
ROYAL BANK OF CANADA | 02/14/2025 | 85,525 | $207,000 | 1,923.30% | 0.21% |
CITADEL ADVISORS LLC | 02/14/2025 | 72,489 | $175,424 | 238.70% | 0.18% |
STATE STREET CORP | 02/14/2025 | 60,818 | $147,180 | 1.27% | 0.15% |
SQUAREPOINT OPS LLC | 02/14/2025 | 54,439 | $131,742 | -34.69% | 0.13% |
JANE STREET GROUP, LLC | 02/14/2025 | 49,663 | $120,184 | -14.81% | 0.12% |
MORGAN STANLEY | 02/14/2025 | 34,633 | $83,811 | -22.44% | 0.08% |
MARQUETTE ASSET MANAGEMENT, LLC | 01/14/2025 | 33,311 | $80,613 | 100.00% | 0.08% |
PNC FINANCIAL SERVICES GROUP, INC. | 02/07/2025 | 26,200 | $63,404 | 0.00% | 0.06% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 25,455 | $61,601 | 0.00% | 0.06% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 24,381 | $59,002 | -47.76% | 0.06% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 23,586 | $57,077 | -5.98% | 0.06% |
WORLD EQUITY GROUP, INC. | 02/04/2025 | 20,000 | $48,400 | 100.00% | 0.05% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 19,591 | $47,410 | 0.00% | 0.05% |
LPL FINANCIAL LLC | 02/11/2025 | 17,431 | $42,183 | -54.94% | 0.04% |
ATRIA INVESTMENTS, INC | 02/06/2025 | 17,426 | $42,171 | -3.21% | 0.04% |
CITADEL ADVISORS LLC | 02/14/2025 | 17,400 | $42,108 | 335.00% | 0.04% |
SAGE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 16,750 | $40,535 | 0.00% | 0.04% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 16,000 | $38,720 | 100.00% | 0.04% |
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 03/17/2025 | 13,799 | $33,394 | 22.12% | 0.03% |
PRELUDE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 13,735 | $33,239 | -4.85% | 0.03% |
BARCLAYS PLC | 02/13/2025 | 13,198 | $32,000 | -0.31% | 0.03% |
JOURNEY STRATEGIC WEALTH LLC | 01/24/2025 | 12,489 | $30,224 | 1.72% | 0.03% |
N.E.W. ADVISORY SERVICES LLC | 01/24/2025 | 12,360 | $29,911 | 0.00% | 0.03% |
ALTSHULER SHAHAM LTD | 02/13/2025 | 11,854 | $28,631 | -1.38% | 0.03% |
CLOSE ASSET MANAGEMENT LTD | 01/28/2025 | 11,400 | $28,000 | 0.00% | 0.03% |
GLASS JACOBSON INVESTMENT ADVISORS LLC | 02/13/2025 | 10,540 | $25,507 | 0.00% | 0.03% |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/06/2025 | 8,826 | $21,359 | 0.00% | 0.02% |
WEALTHFRONT ADVISERS LLC | 02/07/2025 | 8,693 | $974,138 | 100.00% | 0.02% |
SIMPLEX TRADING, LLC | 02/11/2025 | 3,857 | $9,000 | 100.00% | 0.01% |
ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 3,849 | $9,389 | 0.00% | 0.01% |
CITADEL ADVISORS LLC | 02/14/2025 | 3,500 | $8,470 | 66.67% | 0.01% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 2,645 | $6,401 | -66.93% | 0.01% |
NATIONAL BANK OF CANADA /FI/ | 02/12/2025 | 2,500 | $6,050 | 100.00% | 0.01% |
FMR LLC | 02/13/2025 | 1,700 | $4,114 | 13.33% | 0.00% |
02/06/2025 | 1,640 | $3,969 | 100.00% | 0.00% | |
JONES FINANCIAL COMPANIES LLLP | 02/06/2025 | 1,072 | $2,594 | 87.41% | 0.00% |
Oramed Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 73 institutional investors and hedge funds held shares of Oramed Pharmaceuticals Inc.. The most heavily invested institutionals were:
WORLD EQUITY GROUP, INC.: 0
Marquette Asset Management, LLC: 0
BML Capital Management, LLC: 2.64 M
Murchinson Ltd.: 1.75 M
BOOTHBAY FUND MANAGEMENT, LLC: 845,188
Rathbones Group PLC: 289,803
18.76% of Oramed Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 8.72 M shares in the last 24 months. This purchase volume represents approximately $20.14 M in transactions.